NEUROPACE, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
NEUROPACE, INC. (NPCE) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of -5.40% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2026-03-03
- NEUROPACE, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2025 was -5.40%.
- NEUROPACE, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2024 was -5.10%.
- NEUROPACE, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2023 was -1.80%.
- NEUROPACE, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was -1.40%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month |
|---|---|
| 2025-12-31 | -5.40% 10-K · filed 2026-03-03 |
| 2024-12-31 | -5.10% 10-K · filed 2026-03-03 |
| 2023-12-31 | -1.80% 10-K · filed 2025-03-04 |
| 2022-12-31 | -1.40% 10-K · filed 2024-03-05 |
| 2021-12-31 | -1.30% 10-K · filed 2023-03-02 |
| 2020-12-31 | -2.40% 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |